Eldorado Hotel & Spa Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Uncomplicating Diabetes: Reducing the Burden of Diabetes-Related End-Organ Injury (J7)

joint with the meeting on Vascular Biology and Human Diseases: From Molecular Pathways to Novel Therapeutics (J8)

Scientific Organizers: Mark E. Cooper, Thomas M. Coffman, Matthias G. von Herrath and Susan Quaggin


February 25—March 1, 2018

Eldorado Hotel & Spa, Santa Fe, New Mexico, USA


Sponsored by Novo Nordisk A/S


IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
Scholarship Deadline: Nov 16, 2017 [details]
Discounted Abstract Deadline: Nov 16, 2017 [details]
Abstract Deadline: Nov 28, 2017 [details]
Discounted Registration Deadline: Dec 20, 2017 [details]

Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2018-J7 "Uncomplicating Diabetes: Reducing the Burden of Diabetes-Related End-Organ Injury" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On November 16, 2017 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After November 16, 2017 until January 14, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
November 16, 2017 n/a
Discounted NON-STUDENT Registration
More details
Before and On December 20, 2017 820.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After December 20, 2017 1020.00 USD
Discounted STUDENT Registration
More details
Before and On December 20, 2017 595.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After December 20, 2017 795.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: November 16, 2017


Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is November 28, 2017)

Global Health Travel Award Deadline:


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: November 16, 2017


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: November 28, 2017


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is November 16, 2017)

Discounted Registration Deadline: December 20, 2017


Registration Fee: 820.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 595.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1020.00 USD*
Student Registration Fee: 795.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, February 25 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 1 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 2 in order to fully experience the meeting.

SUNDAY, FEBRUARY 25

16:00—20:00
Arrival and Registration

Eldorado Lounge
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Eldorado Lounge

MONDAY, FEBRUARY 26

07:00—08:00
Breakfast

Anasazi Ballroom
08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
Steven E. Kahn, VA Puget Sound Health Care System and University of Washington, USA
Current Management of Type 2 Diabetes

08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
Kari K. Alitalo, University of Helsinki, Finland
Therapeutic Potential of Vascular Growth Factors

09:00—11:15
New Treatments in Diabetes
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
Daniel J. Drucker, Lunenfeld-Tanenbaum Research Institute, Canada
GLP-1-Mediated Reduction in Complications of Diabetes

Coffee Break

Volker Vallon, UC San Diego & VA San Diego Healthcare System, USA
SGLT2 Inhibition – Insights from Experimental Studies

David Cherney, University of Toronto, Canada
SGLT2 Inhibition: Renal Effects in Man

Short Talk(s) Chosen from Abstracts

09:00—11:15
Vascular Growth Factors: Biological Relevance and Therapeutic Application
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
Michael Simons, Yale University, USA
Cell Type Specificity of FGF/TGF Signaling

Coffee Break

Lena Claesson-Welsh, Uppsala University, Sweden
Phosphatases in Vascular Permeability and Angiogenesis

Shahin Rafii, Weill Cornell Medical College, USA
Angiocrine Functions of Endothelial Cells

Short Talk(s) Chosen from Abstracts

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Anasazi Ballroom
13:00—22:00
Poster Viewing

Anasazi Ballroom
16:30—17:00
Coffee Available

Concourse
17:00—19:00
Lipids and Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
Katalin Susztak, University of Pennsylvania, USA
Lipids and Renal Tubular Injury in Diabetes

Weier Qi, AstraZeneca, Sweden
Human Proteomics to Therapeutics for Diabetic Nephropathy - The 50-Year Joslin Medalist Study

Short Talk Chosen from Abstracts

17:00—19:00
Vascular Growth Factors: Receptors and Biological Role
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
Gou Young Koh, Institute of Basic Science, South Korea
Tie2 Activating Antibody “ABTAA” for Micro-vascular Diseases

Gavin O. Thurston, Regeneron Pharmaceuticals Inc., USA
Endothelial Heterogeneity and Response to Anti-Vascular Therapy

Luisa Iruela-Arispe, University of California, Los Angeles, USA
Critical Signaling Nodes in Vascular Homeostasis

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Anasazi Ballroom
19:30—22:00
Poster Session 1

Anasazi Ballroom

TUESDAY, FEBRUARY 27

07:00—08:00
Breakfast

Anasazi Ballroom
08:00—11:00
Endothelial Metabolism and Neurovascular Crosstalk (Joint)
Registered attendees can view abstracts starting on 01/25/2018

Eldorado Grand Ballroom
Peter F. Carmeliet, University of Leuven, VIB, Belgium
Endothelial Cell Metabolism and Therapeutic Interventions

Susan Quaggin, Northwestern University, USA
Therapies on the Horizon of Diabetic Kidney Disease

Coffee Break

Anne C. Eichmann, Yale University School of Medicine, USA
Neurovascular Cross Talk and Possible Pathological Implications

David L. Silver, Duke-NUS Medical School, Singapore
Brain Lipid Transport

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Anasazi Ballroom
13:00—22:00
Poster Viewing

Anasazi Ballroom
16:30—17:00
Coffee Available

Concourse
17:00—19:15
Mitochondria and Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
Richard J. Youle, NINDS, National Institutes of Health, USA
General Overview on Mito Maven

Chengxue Helena Qin, Baker IDI Heart and Diabetes Institute, Australia
Role of Endogenous Annexin-A1 in the Cardiovascular Response to Diabetes

Farhad Danesh, University of Texas MD Anderson Cancer Center, USA
Mitochondrial Reprogramming in Diabetic Nephropathy

Svati H. Shah, Duke University Medical Center, USA
What Can We Learn from Metabolomics?

17:00—19:00
Regulation of Endothelial Cell Differentiation in Development and Tissue Regeneration
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
Didier Stainier, Max Planck Institute for Heart and Lung Research, Germany
Vascular Development in Zebrafish

Taija Mäkinen, Uppsala University, Sweden
Mechanisms of Lymphatic Vessel Formation from Progenitors of Different Origins

Hellmut G. Augustin, DKFZ & Heidelberg University, Germany
Epigenetic Regulation Vascular Maturation

Short Talk Chosen from Abstracts

19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Anasazi Ballroom
19:30—22:00
Poster Session 2

Anasazi Ballroom

WEDNESDAY, FEBRUARY 28

07:00—08:00
Breakfast

Anasazi Ballroom
08:00—11:00
Genomics and Epigenomics in Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
Eske Willerslev, University of Copenhagen, Denmark
What We Can Learn from State of the Art Genomics?

Mark I. McCarthy, University of Oxford, UK
Using human genetics for biological insight and translational advantage

Coffee Break

Thomas M. Coffman, NUS Duke SIngapore, Singapore
Genetic Mechanisms of Diabetic Kidney Disease in Mouse Models

Assam El-Osta, Baker IDI Heart Research Institute, Australia
Epigenetics of Diabetes and its Complications. Beyond Epiphenomenon?

Short Talk(s) Chosen from Abstracts

08:00—11:00
Molecular Basis of Vascular Diversity
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
Ralf H. Adams, Max Planck Institute for Molecular Biomedicine, Germany
Organ-Specific and Functional Specialization of Blood Vessels

Costantino Iadecola, Weill Cornell Medicine, USA
The Diversity of the Brain Microcirculation in Health and Disease

Coffee Break

Britta Engelhardt, Theodor Kocher Institute/Universitat Bern, Switzerland
Specialized Brain Barriers Establish the Immune Privilege of the CNS

Stefan Liebner, Klinikum der Johann Wolfgang Goethe-Universität, Germany
Role of Astrocyte-derived Wnt Growth Factors for Endothelial Blood-brain Barrier Maintenance

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Anasazi Ballroom
13:00—22:00
Poster Viewing

Anasazi Ballroom
16:30—17:00
Coffee Available

Concourse
17:00—19:00
Oxidative Stress and Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
Patrick J. Pagano, University of Pittsburgh, USA
ROS in Vascular Phenotypic Switching and Disease, Target Nox!

Karin Agnes Maria Jandeleit-Dahm, Monash University, Australia
The Role of Reactive Oxygen Species in Diabetic Complications

Kumar Sharma, University of California, San Diego, USA
Mitochondrial ROS: Friend or Foe?

Short Talk Chosen from Abstracts

17:00—19:00
Brain Vascular Pathology
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
Christer Betsholtz, Uppsala University, Sweden
The Establishment and Dysfunction of the Blood Brain Barrier

Elisabetta Dejana, Uppsala University, Sweden
Transcriptional Regulation of the Blood Brain Barrier in Health and Disease

Speaker to be Announced

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Anasazi Ballroom
19:30—22:00
Poster Session 3

Anasazi Ballroom

THURSDAY, MARCH 1

07:00—08:00
Breakfast

Anasazi Ballroom
08:00—11:00
Inflammation, the Vasculature and Diabetic Complications (Joint)
Registered attendees can view abstracts starting on 01/25/2018

Eldorado Grand Ballroom
Speaker to be Announced

Andrew J. Murphy, Baker Heart Research Institute, Australia
Hematopoietic Progenitor Cells in Diabetic Complications

Coffee Break

Lois E. H. Smith, Boston Children's Hospital/ Harvard Medical School, USA
FGF21 protects against early diabetic retinopathy

Israel F. Charo, ChemoCentryx, Inc., USA
Targeting CCR2 for Treatment of Renal Diseases

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Concourse
17:00—18:45
Vasoactive Hormones in Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
Ariela Benigni, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Italy
Regeneration of Kidney Vasculature by Angiotensin II Antagonism: New Insights

Susan Gurley, Duke University, USA
Angiotensin II: Tissue-Selective Effects

Merlin Thomas, Monash University, Australia
Novel Interactions of RAGE with GPCR Receptors

17:00—18:45
Hemodynamics and Endothelial Pathology
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
Martin Schwartz, Yale School of Medicine, USA
Endothelial Fluid Shear Stress Responses in Vascular Remodeling and Atherosclerosis

Naoki Mochizuki, National Cerebral and Cardiovascular Center Research Institute, Japan
The Responses of Endothelial Cells to the Flow

Tatiana V. Petrova, CHUV and University of Lausanne, Switzerland
Endothelial Cell Responses to Biomechanical Forces in Lymphatics

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Anasazi Ballroom
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Anasazi Ballroom

FRIDAY, MARCH 2

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsor for generously supporting this meeting:

Novo Nordisk A/S

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1 R13 DK116595-01

Funding for this conference was made possible (in part) by 1 R13 DK116595-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional support for this conference from:

eLife

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Eli Lilly and Company


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676